Clinical Trials Browser

Phase NA × Carcinoma, Medullary × Endocrine × Clear all

Thyroid cancer, medullary, Thyroid Neoplasms, Carcinoma, Medullary

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Phase NA Completed

23 enrolled

CNSEndocrine

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

NCT00416949 2018-07-18

Iodine I 131 in Treating Patients With Thyroid Cancer

Phase NA Terminated

9 enrolled 4 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT01927887 2017-06-06

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Phase NA Completed

12 enrolled 6 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Medullary

NCT00068497 2013-01-14

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase NA Completed

40 enrolled

CNSEndocrineHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Clinical Trials

MIMETIC

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Iodine I 131 in Treating Patients With Thyroid Cancer

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer